Showing results (171-180 of 325) with videos related to
Sort By:
Pageof 33
Antimicrobial Agents and Chemotherapy|September 18, 2024
Serum ganciclovir drug exposure in children receiving standard ganciclovir dosingWenyu Yang, Adam Irwin, Heather Weerdenburg, et al.Antimicrobial Agents and Chemotherapy|May 12, 2026
Model-informed precision dosing of vancomycin in children 3 months to 18 years of age using Australia-wide dataHaiping Xu, Wenyu Yang, Tony Lai, et al.Journal of Paediatrics and Child Health|February 27, 2013
Central venous access device-related infections in patients with haemophiliaZhi Han Yeoh, Janine Furmedge, Julia Ekert, et al.The Journal of Antimicrobial Chemotherapy|April 17, 2024
Inappropriate prescribing contributes to high antibiotic exposure in young children in AustraliaStejara A Netea, Nicole L Messina, Kaya Gardiner, et al.The Pediatric Infectious Disease Journal|October 24, 2002
Clinical implications of inducible beta-lactamase activity in Gram-negative bacteremia in childrenRobert J Boyle, Nigel Curtis, Nigel Kelly, et al.FEMS Microbiology Reviews|July 12, 2008
Influence of BCG vaccine strain on the immune response and protection against tuberculosisNicole Ritz, Willem A Hanekom, Roy Robins-Browne, et al.Internal Medicine Journal|September 7, 2021
Prospective study of policies and use of therapies for COVID-19 among Australian health services during 2020Emma L Smith, Amanda Gwee, Jason A Roberts, et al.Antimicrobial Agents and Chemotherapy|July 23, 2025
Personalized tobramycin dosing in children with cystic fibrosis: an AUC24-guided approachKiera H Harwood, Stephen Duffull, Shivanthan Shanthikumar, et al.Archives of Disease in Childhood|March 5, 2026
Invasive pneumococcal disease in children with acute lymphoblastic leukaemiaLinny Kimly Phuong, Amanda Gwee, Christopher C Blyth, et al.Antimicrobial Agents and Chemotherapy|October 29, 2008
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibioticsNicole Ritz, Marc Tebruegge, Tom G Connell, et al.Pageof 33